HTLV-1 infection and adult T-cell leukemia/ lymphoma-A tale of two proteins: Tax and HBZ

Viruses

Volumn 8, Issue 6, 2016, Pages

  Giam, Chou Zen ^a   Semmes, Oliver John ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Adult T cell leukemia; DNA damage response; Genomic instability; HTLV 1; K63 linked polyubiquitin; Latency and persistence; RNF8; Senescence; UBC13

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN D1; GUANINE NUCLEOTIDE EXCHANGE FACTOR; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAMMALIAN TARGET OF RAPAMYCIN; NIBRIN; POL PROTEIN; PROTEIN P21; RAN SPECIFIC BINDING PROTEIN 1; RING FINGER PROTEIN; RING FINGER PROTEIN 8; SERUM RESPONSE FACTOR; TAX PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR JUNB; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VAV GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; HBZ PROTEIN, HUMAN T-CELL LEUKEMIA VIRUS TYPE I; TAX PROTEIN, HUMAN T-LYMPHOTROPHIC VIRUS 1; VIRAL PROTEIN;

APOPTOSIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1 INFECTION; NONHUMAN; PERSISTENT VIRUS INFECTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; T CELL LEUKEMIA; TRANSCRIPTOMICS; UBIQUITINATION; UPREGULATION; VIRUS INFECTION; VIRUS REPLICATION; CARCINOGENESIS; HOST PATHOGEN INTERACTION; METABOLISM; PATHOGENICITY; PATHOLOGY; VIROLOGY; VIRUS LATENCY;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOGENESIS; GENE PRODUCTS, TAX; HOST-PATHOGEN INTERACTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; RETROVIRIDAE PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84975132484     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8060161     Document Type: Review

References (143)

1. Gessain, A.; Cassar, O. Epidemiological aspects and world distribution of HTLV-1 infection. Front. Microbiol. 2012, 3, 388. [CrossRef] [PubMed]
2. Taylor, G.P.; Matsuoka, M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 2005, 24, 6047-6057. [CrossRef] [PubMed]
3. Matsuoka, M.; Jeang, K.T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 2007, 7, 270-280. [CrossRef] [PubMed]
4. Tsukasaki, K.; Hermine, O.; Bazarbachi, A.; Ratner, L.; Ramos, J.C.; Harrington, W., Jr.; O’Mahony, D.; Janik, J.E.; Bittencourt, A.L.; Taylor, G.P. et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. J. Clin. Oncol. 2009, 27, 453-459. [CrossRef] [PubMed]
5. Matsuoka, M.; Green, P.L. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 2009, 6, 71. [CrossRef] [PubMed]
6. Kataoka, K.; Nagata, Y.; Kitanaka, A.; Shiraishi, Y.; Shimamura, T.; Yasunaga, J.; Totoki, Y.; Chiba, K.; Sato-Otsubo, A.; Nagae, G. et al. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat. Genet. 2015, 47, 1304-1315. [CrossRef] [PubMed]
7. Satou, Y.; Yasunaga, J.; Yoshida, M.; Matsuoka, M. HTLV-1 BZIP factor (HBZ) gene has a growth-promoting effect on adult T-cell leukemia cells. Rinsho Ketsueki 2008, 49, 1525-1529. [PubMed]
8. Satou, Y.; Yasunaga, J.; Zhao, T.; Yoshida, M.; Miyazato, P.; Takai, K.; Shimizu, K.; Ohshima, K.; Green, P.L.; Ohkura, N. et al. HTLV-1 BZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011, 7, e1001274. [CrossRef] [PubMed]
9. Arnold, J.; Zimmerman, B.; Li, M.; Lairmore, M.D.; Green, P.L. Human T-cell leukemia virus type-1 antisense-encoded gene, HBZ, promotes T-lymphocyte proliferation. Blood 2008, 112, 3788-3797. [CrossRef] [PubMed]
10. Satou, Y.; Yasunaga, J.; Yoshida, M.; Matsuoka, M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. USA 2006, 103, 720-725. [CrossRef] [PubMed]
11. Chapman, M.A.; Lawrence, M.S.; Keats, J.J.; Cibulskis, K.; Sougnez, C.; Schinzel, A.C.; Harview, C.L.; Brunet, J.P.; Ahmann, G.J.; Adli, M. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011, 471, 467-472. [CrossRef] [PubMed]
12. Marriott, S.J.; Semmes, O.J. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene 2005, 24, 5986-5995. [CrossRef] [PubMed]
13. Majone, F.; Semmes, O.J.; Jeang, K.T. Induction of micronuclei by HTLV-I Tax: A cellular assay for function. Virology 1993, 193, 456-459. [CrossRef] [PubMed]
14. Majone, F.; Jeang, K.T. Clastogenic effect of the human T-cell leukemia virus type I Tax oncoprotein correlates with unstabilized DNA breaks. J. Biol. Chem. 2000, 275, 32906-32910. [CrossRef] [PubMed]
15. Semmes, O.J.; Majone, F.; Cantemir, C.; Turchetto, L.; Hjelle, B.; Jeang, K.T. HTLV-I and HTLV-II Tax: Differences in induction of micronuclei in cells and transcriptional activation of viral LTRS. Virology 1996, 217, 373-379. [CrossRef] [PubMed]
16. Edwards, D.; Fenizia, C.; Gold, H.; de Castro-Amarante, M.F.; Buchmann, C.; Pise-Masison, C.A.; Franchini, G. ORF-I and ORF-II-encoded proteins in HTLV-1 infection and persistence. Viruses 2011, 3, 861-885. [CrossRef] [PubMed]
17. Banerjee, P.; Feuer, G.; Barker, E. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and-2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. J. Virol. 2007, 81, 9707-9717. [PubMed]
18. Pise-Masison, C.A.; de Castro-Amarante, M.F.; Enose-Akahata, Y.; Buchmann, R.C.; Fenizia, C.; Washington Parks, R.; Edwards, D.; Fiocchi, M.; Alcantara, L.C., Jr.; Bialuk, I. et al. Co-dependence of HTLV-1 p12 and p8 functions in virus persistence. PLoS Pathog. 2014, 10, e1004454. [CrossRef] [PubMed]
19. Hiraragi, H.; Michael, B.; Nair, A.; Silic-Benussi, M.; Ciminale, V.; Lairmore, M. Human T-lymphotropic virus type 1 mitochondrion-localizing protein P13II sensitizes jurkat T cells to ras-mediated apoptosis. J. Virol. 2005, 79, 9449-9457. [CrossRef] [PubMed]
20. Andresen, V.; Pise-Masison, C.A.; Sinha-Datta, U.; Bellon, M.; Valeri, V.; Washington Parks, R.; Cecchinato, V.; Fukumoto, R.; Nicot, C.; Franchini, G. Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles. Blood 2011, 118, 1549-1559. [CrossRef] [PubMed]
21. Lefebvre, L.; Vanderplasschen, A.; Ciminale, V.; Heremans, H.; Dangoisse, O.; Jauniaux, J.C.; Toussaint, J.F.; Zelnik, V.; Burny, A.; Kettmann, R. et al. Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J. Virol. 2002, 76, 1400-1414. [CrossRef] [PubMed]
22. Silic-Benussi, M.; Cavallari, I.; Zorzan, T.; Rossi, E.; Hiraragi, H.; Rosato, A.; Horie, K.; Saggioro, D.; Lairmore, M.D.; Willems, L. et al. Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc. Natl. Acad. Sci. USA 2004, 101, 6629-6634. [CrossRef] [PubMed]
23. Nicot, C.; Dundr, M.; Johnson, J.M.; Fullen, J.R.; Alonzo, N.; Fukumoto, R.; Princler, G.L.; Derse, D.; Misteli, T.; Franchini, G. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat. Med. 2004, 10, 197-201. [CrossRef] [PubMed]
24. Yoshida, M.; Satou, Y.; Yasunaga, J.; Fujisawa, J.; Matsuoka, M. Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 BZIP factor (HBZ) gene. J. Virol. 2008, 82, 9359-9368. [CrossRef] [PubMed]
25. Manel, N.; Kim, F.J.; Kinet, S.; Taylor, N.; Sitbon, M.; Battini, J.L. The ubiquitous glucose transporter glut-1 is a receptor for HTLV. Cell 2003, 115, 449-459. [CrossRef]
26. Lambert, S.; Bouttier, M.; Vassy, R.; Seigneuret, M.; Petrow-Sadowski, C.; Janvier, S.; Heveker, N.; Ruscetti, F.W.; Perret, G.; Jones, K.S. et al. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165. Blood 2009, 113, 5176-5185. [CrossRef] [PubMed]
27. Jones, K.S.; Petrow-Sadowski, C.; Bertolette, D.C.; Huang, Y.; Ruscetti, F.W. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J. Virol. 2005, 79, 12692-12702. [CrossRef] [PubMed]
28. Igakura, T.; Stinchcombe, J.C.; Goon, P.K.; Taylor, G.P.; Weber, J.N.; Griffiths, G.M.; Tanaka, Y.; Osame, M.; Bangham, C.R. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003, 299, 1713-1716. [CrossRef] [PubMed]
29. Barnard, A.L.; Igakura, T.; Tanaka, Y.; Taylor, G.P.; Bangham, C.R. Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. Blood 2005, 106, 988-995. [CrossRef] [PubMed]
30. Derse, D.; Hill, S.A.; Lloyd, P.A.; Chung, H.; Morse, B.A. Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J. Virol. 2001, 75, 8461-8468. [CrossRef] [PubMed]
31. Mazurov, D.; Ilinskaya, A.; Heidecker, G.; Lloyd, P.; Derse, D. Quantitative comparison of HTLV-1 and hiv-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathog. 2010, 6, e1000788. [CrossRef] [PubMed]
32. Nejmeddine, M.; Barnard, A.L.; Tanaka, Y.; Taylor, G.P.; Bangham, C.R. Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J. Biol. Chem. 2005, 280, 29653-29660. [CrossRef] [PubMed]
33. Nejmeddine, M.; Negi, V.S.; Mukherjee, S.; Tanaka, Y.; Orth, K.; Taylor, G.P.; Bangham, C.R. HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood 2009, 114, 1016-1025. [CrossRef] [PubMed]
34. Jones, K.S.; Petrow-Sadowski, C.; Huang, Y.K.; Bertolette, D.C.; Ruscetti, F.W. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat. Med. 2008, 14, 429-436. [CrossRef] [PubMed]
35. Jain, P.; Manuel, S.L.; Khan, Z.K.; Ahuja, J.; Quann, K.; Wigdahl, B. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. J. Virol. 2009, 83, 10908-10921. [CrossRef] [PubMed]
36. De Castro-Amarante, M.F.; Pise-Masison, C.A.; McKinnon, K.; Washington Parks, R.; Galli, V.; Omsland, M.; Andresen, V.; Massoud, R.; Brunetto, G.; Caruso, B. et al. Human T cell leukemia virus type 1 infection of the three monocyte subsets contributes to viral burden in humans. J. Virol. 2015, 90, 2195-2207. [CrossRef] [PubMed]
37. Gross, C.; Thoma-Kress, A.K. Molecular mechanisms of HTLV-1 cell-to-cell transmission. Viruses 2016, 8, 74. [CrossRef] [PubMed]
38. Pais-Correia, A.M.; Sachse, M.; Guadagnini, S.; Robbiati, V.; Lasserre, R.; Gessain, A.; Gout, O.; Alcover, A.; Thoulouze, M.I. Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat. Med. 2010, 16, 83-89. [CrossRef] [PubMed]
39. Jaworski, E.; Narayanan, A.; Van Duyne, R.; Shabbeer-Meyering, S.; Iordanskiy, S.; Saifuddin, M.; Das, R.; Afonso, P.V.; Sampey, G.C.; Chung, M. et al. Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein. J. Biol. Chem. 2014, 289, 22284-22305. [CrossRef] [PubMed]
40. Van Dooren, S.; Pybus, O.G.; Salemi, M.; Liu, H.F.; Goubau, P.; Remondegui, C.; Talarmin, A.; Gotuzzo, E.; Alcantara, L.C.; Galvao-Castro, B. et al. The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains. Mol. Biol. Evol. 2004, 21, 603-611. [CrossRef] [PubMed]
41. Asquith, B.; Hanon, E.; Taylor, G.P.; Bangham, C.R. Is human T-cell lymphotropic virus type I really silent? Philos. Trans. R. Soc. Lond. B Biol. Sci. 2000, 355, 1013-1019. [CrossRef] [PubMed]
42. Bangham, C.R.; Osame, M. Cellular immune response to HTLV-1. Oncogene 2005, 24, 6035-6046. [CrossRef] [PubMed]
43. Hanon, E.; Hall, S.; Taylor, G.P.; Saito, M.; Davis, R.; Tanaka, Y.; Usuku, K.; Osame, M.; Weber, J.N.; Bangham CR, L.H. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000, 15, 1386-1392.
44. Tanaka, G.; Okayama, A.; Watanabe, T.; Aizawa, S.; Stuver, S.; Mueller, N.; Hsieh, C.C.; Tsubouchi, H. The clonal expansion of human T lymphotropic virus type 1-infected T cells: A comparison between seroconverters and long-term carriers. J. Infect. Dis. 2005, 191, 1140-1147. [CrossRef] [PubMed]
45. Okayama, A.; Stuver, S.; Matsuoka, M.; Ishizaki, J.; Tanaka, G.; Kubuki, Y.; Mueller, N.; Hsieh, C.C.; Tachibana, N.; Tsubouchi, H. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int. J. Cancer 2004, 110, 621-625. [CrossRef] [PubMed]
46. Umeki, K.; Hisada, M.; Maloney, E.M.; Hanchard, B.; Okayama, A. Proviral loads and clonal expansion of HTLV-1-infected cells following vertical transmission: A 10-year follow-up of children in Jamaica. Intervirology 2009, 52, 115-122. [CrossRef] [PubMed]
47. Niederer, H.A.; Bangham, C.R. Integration site and clonal expansion in human chronic retroviral infection and gene therapy. Viruses 2014, 6, 4140-4164. [CrossRef] [PubMed]
48. Cook, L.B.; Rowan, A.G.; Melamed, A.; Taylor, G.P.; Bangham, C.R. HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood 2012, 120, 3488-3490. [CrossRef] [PubMed]
49. Cook, L.B.; Melamed, A.; Niederer, H.; Valganon, M.; Laydon, D.; Foroni, L.; Taylor, G.P.; Matsuoka, M.; Bangham, C.R. The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. Blood 2014, 123, 3925-3931. [CrossRef] [PubMed]
50. Derse, D.; Crise, B.; Li, Y.; Princler, G.; Lum, N.; Stewart, C.; McGrath, C.F.; Hughes, S.H.; Munroe, D.J.; Wu, X. Human T-cell leukemia virus type 1 integration target sites in the human genome: Comparison with those of other retroviruses. J. Virol. 2007, 81, 6731-6741. [CrossRef] [PubMed]
51. Meekings, K.N.; Leipzig, J.; Bushman, F.D.; Taylor, G.P.; Bangham, C.R. HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog. 2008, 4, e1000027. [CrossRef] [PubMed]
52. Takeda, S.; Maeda, M.; Morikawa, S.; Taniguchi, Y.; Yasunaga, J.; Nosaka, K.; Tanaka, Y.; Matsuoka, M. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int. J. Cancer 2004, 109, 559-567. [CrossRef] [PubMed]
53. Taniguchi, Y.; Nosaka, K.; Yasunaga, J.; Maeda, M.; Mueller, N.; Okayama, A.; Matsuoka, M. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2005, 2, 64. [CrossRef] [PubMed]
54. Liu, M.; Yang, L.; Zhang, L.; Liu, B.; Merling, R.; Xia, Z.; Giam, C.Z. Human T-cell leukemia virus type 1 infection leads to arrest in the G1 phase of the cell cycle. J. Virol. 2008, 82, 8442-8455. [CrossRef] [PubMed]
55. Philip, S.; Zahoor, M.A.; Zhi, H.; Ho, Y.K.; Giam, C.Z. Regulation of human T-lymphotropic virus type I latency and reactivation by HBZ and Rex. PLoS Pathog. 2014, 10, e1004040. [CrossRef] [PubMed]
56. Kuo, Y.L.; Giam, C.Z. Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence. EMBO J. 2006, 25, 1741-1752. [CrossRef] [PubMed]
57. Zhi, H.; Yang, L.; Kuo, Y.L.; Ho, Y.K.; Shih, H.M.; Giam, C.Z. NF-κB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ. PLoS Pathog. 2011, 7, e1002025. [CrossRef] [PubMed]
58. Anderson, M.D.; Ye, J.; Xie, L.; Green, P.L. Transformation studies with a human T-cell leukemia virus type 1 molecular clone. J. Virol. Methods 2004, 116, 195-202. [CrossRef] [PubMed]
59. Derse, D.; Heidecker, G.; Mitchell, M.; Hill, S.; Lloyd, P.; Princler, G. Infectious transmission and replication of human T-cell leukemia virus type 1. Front. Biosci. 2004, 9, 2495-2499. [CrossRef] [PubMed]
60. Hasegawa, H.; Sawa, H.; Lewis, M.J.; Orba, Y.; Sheehy, N.; Yamamoto, Y.; Ichinohe, T.; Tsunetsugu-Yokota, Y.; Katano, H.; Takahashi, H. et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 2006, 12, 466-472. [CrossRef] [PubMed]
61. Nerenberg, M.; Hinrichs, S.H.; Reynolds, R.K.; Khoury, G.; Jay, G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 1987, 237, 1324-1329. [CrossRef] [PubMed]
62. Grossman, W.J.; Kimata, J.T.; Wong, F.H.; Zutter, M.; Ley, T.J.; Ratner, L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA. 1995, 92, 1057-1061. [CrossRef] [PubMed]
63. Yamaoka, S.; Tobe, T.; Hatanaka, M. Tax protein of human T-cell leukemia virus type I is required for maintenance of the transformed phenotype. Oncogene 1992, 7, 433-437. [PubMed]
64. Panfil, A.R.; Al-Saleem, J.J.; Green, P.L. Animal models utilized in HTLV-1 research. Virology 2013, 4, 49-59. [PubMed]
65. Dodon, M.D.; Villaudy, J.; Gazzolo, L.; Haines, R.; Lairmore, M. What we are learning on HTLV-1 pathogenesis from animal models. Front. Microbiol. 2012, 3, 320. [CrossRef] [PubMed]
66. Li, M.; Kesic, M.; Yin, H.; Yu, L.; Green, P.L. Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals. J. Virol. 2009, 83, 3788-3797. [CrossRef] [PubMed]
67. Pozzatti, R.; Vogel, J.; Jay, G. The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol. Cell Biol. 1990, 10, 413-417. [CrossRef] [PubMed]
68. Semmes, O.J.; Barret, J.F.; Dang, C.V.; Jeang, K.T. Human T-cell leukemia virus type I Tax masks c-Myc function through a cAMP-dependent pathway. J. Biol. Chem. 1996, 271, 9730-9738. [PubMed]
69. Zahoor, M.A.; Philip, S.; Zhi, H.; Giam, C.Z. NF-κB inhibition facilitates the establishment of cell lines that chronically produce human T-lymphotropic virus type 1 viral particles. J. Virol. 2014, 88, 3496-3504. [CrossRef] [PubMed]
70. Tripp, A.; Banerjee, P.; Sieburg, M.; Planelles, V.; Li, F.; Feuer, G. Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: Modulation of p21cip1/waf1 and p27kip1 expression. J. Virol. 2005, 79, 14069-14078. [CrossRef] [PubMed]
71. De La Fuente, C.; Santiago, F.; Chong, S.Y.; Deng, L.; Mayhood, T.; Fu, P.; Stein, D.; Denny, T.; Coffman, F.; Azimi, N. et al. Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2. J. Virol. 2000, 74, 7270-7283. [CrossRef] [PubMed]
72. Zhang, L.; Zhi, H.; Liu, M.; Kuo, Y.L.; Giam, C.Z. Induction of p21(CIP1/WAF1) expression by human T-lymphotropic virus type 1 Tax requires transcriptional activation and mrna stabilization. Retrovirology 2009, 6, 35. [CrossRef] [PubMed]
73. Cereseto, A.; Washington, P.R.; Rivadeneira, E.; Franchini, G. Limiting amounts of p27kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Oncogene 1999, 18, 2441-2450. [CrossRef] [PubMed]
74. Chlichlia, K.; Moldenhauer, G.; Daniel, P.T.; Busslinger, M.; Gazzolo, L.; Schirrmacher, V.; Khazaie, K. Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis. Oncogene 1995, 10, 269-277. [PubMed]
75. Hall, A.P.; Irvine, J.; Blyth, K.; Cameron, E.R.; Onions, D.E.; Campbell, M.E. Tumours derived from HTLV-I tax transgenic mice are characterized by enhanced levels of apoptosis and oncogene expression. J. Pathol. 1998, 186, 209-214. [CrossRef]
76. Haoudi, A.; Semmes, O.J. The HTLV-1 tax oncoprotein attenuates DNA damage induced G1 arrest and enhances apoptosis in p53 null cells. Virology 2003, 305, 229-239. [CrossRef] [PubMed]
77. Rivera-Walsh, I.; Waterfield, M.; Xiao, G.; Fong, A.; Sun, S.C. NF-kappab signaling pathway governs trail gene expression and human T-cell leukemia virus-I tax-induced T-cell death. J. Biol. Chem. 2001, 276, 40385-40388. [CrossRef] [PubMed]
78. Yamada, T.; Yamaoka, S.; Goto, T.; Nakai, M.; Tsujimoto, Y.; Hatanaka, M. The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. J. Virol. 1994, 68, 3374-3379. [PubMed]
79. Tsukahara, T.; Kannagi, M.; Ohashi, T.; Kato, H.; Arai, M.; Nunez, G.; Iwanaga, Y.; Yamamoto, N.; Ohtani, K.; Nakamura, M. et al. Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J. Virol. 1999, 73, 7981-7987. [PubMed]
80. Takahashi, M.; Higuchi, M.; Makokha, G.N.; Matsuki, H.; Yoshita, M.; Tanaka, Y.; Fujii, M. HTLV-1 Tax oncoprotein stimulates ROS production and apoptosis in T cells by interacting with USP10. Blood 2013, 122, 715-725. [CrossRef] [PubMed]
81. Hoenicke, L.; Zender, L. Immune surveillance of senescent cells-Biological significance in cancer-and non-cancer pathologies. Carcinogenesis 2012, 33, 1123-1126. [CrossRef] [PubMed]
82. Barbeau, B.; Mesnard, J.M. Making sense out of antisense transcription in human T-cell lymphotropic viruses (HTLVs). Viruses 2011, 3, 456-468. [CrossRef] [PubMed]
83. Clerc, I.; Polakowski, N.; André-Arpin, C.; Cook, P.; Barbeau, B.; Mesnard, J.M.; Lemasson, I. An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the downregulation of tax-dependent viral transcription by HBZ. J. Biol. Chem. 2008, 283, 23903-23913. [CrossRef] [PubMed]
84. Lemasson, I.; Lewis, M.R.; Polakowski, N.; Hivin, P.; Cavanagh, M.H.; Thebault, S.; Barbeau, B.; Nyborg, J.K.; Mesnard, J.M. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J. Virol. 2007, 81, 1543-1553. [CrossRef] [PubMed]
85. Gaudray, G.; Gachon, F.; Basbous, J.; Biard-Piechaczyk, M.; Devaux, C.; Mesnard, J.M. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 2002, 76, 12813-12822. [CrossRef] [PubMed]
86. Zhao, T.; Yasunaga, J.; Satou, Y.; Nakao, M.; Takahashi, M.; Fujii, M.; Matsuoka, M. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB. Blood 2009, 113, 2755-2764. [CrossRef] [PubMed]
87. Zhi, H.; Zahoor, M.A.; Shudofsky, A.M.; Giam, C.Z. KSHV vCyclin counters the senescence/G1 arrest response triggered by NF-κB hyperactivation. Oncogene 2014, 34, 496-505. [CrossRef] [PubMed]
88. Fontenot, J.D.; Gavin, M.A.; Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4, 330-336. [CrossRef] [PubMed]
89. Grant, C.; Oh, U.; Fugo, K.; Takenouchi, N.; Griffith, C.; Yao, K.; Newhook, T.E.; Ratner, L.; Jacobson, S. Foxp3 represses retroviral transcription by targeting both NF-κB and CREB pathways. PLoS Pathog. 2006, 2, e33. [CrossRef] [PubMed]
90. Bettelli, E.; Dastrange, M.; Oukka, M. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 2005, 102, 5138-5143. [CrossRef] [PubMed]
91. Chen, S.; Ishii, N.; Ine, S.; Ikeda, S.; Fujimura, T.; Ndhlovu, L.C.; Soroosh, P.; Tada, K.; Harigae, H.; Kameoka, J. et al. Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int. Immunol. 2006, 18, 269-277. [CrossRef] [PubMed]
92. Kawata, S.; Ariumi, Y.; Shimotohno, K. p21(Waf1/Cip1/Sdi1) prevents apoptosis as well as stimulates growth in cells transformed or immortalized by human T-cell leukemia virus type 1-encoded tax. J. Virol. 2003, 77, 7291-7299. [CrossRef] [PubMed]
93. Watanabe, M.; Nakahata, S.; Hamasaki, M.; Saito, Y.; Kawano, Y.; Hidaka, T.; Yamashita, K.; Umeki, K.; Taki, T.; Taniwaki, M. et al. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines. J. Virol. 2010, 84, 6966-6977. [CrossRef] [PubMed]
94. Jeang, K.T.; Giam, C.Z.; Majone, F.; Aboud, M. Life, death, and tax: Role of HTLV-I oncoprotein in genetic instability and cellular transformation. J. Biol. Chem. 2004, 279, 31991-31994. [CrossRef] [PubMed]
95. Lemoine, F.J.; Marriott, S.J. Genomic instability driven by the human T-cell leukemia virus type I (HTLV-I) oncoprotein, tax. Oncogene 2002, 21, 7230-7234. [CrossRef] [PubMed]
96. Jeang, K.T.; Widen, S.G.; Semmes, O.J.; Wilson, S.H. HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science 1990, 247, 1082-1084. [CrossRef] [PubMed]
97. Baydoun, H.H.; Cherian, M.A.; Green, P.; Ratner, L. Inducible nitric oxide synthase mediates DNA double strand breaks in human T-cell leukemia virus type 1-induced leukemia/lymphoma. Retrovirology 2015, 12, 71. [CrossRef] [PubMed]
98. Belgnaoui, S.M.; Fryrear, K.A.; Nyalwidhe, J.O.; Guo, X.; Semmes, O.J. The viral oncoprotein tax sequesters DNA damage response factors by tethering MDC1 to chromatin. J. Biol. Chem. 2010, 285, 32897-32905. [CrossRef] [PubMed]
99. Haoudi, A.; Daniels, R.C.; Wong, E.; Kupfer, G.; Semmes, O.J. Human T-cell leukemia virus-I tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damage-response. J. Biol. Chem. 2003, 278, 37736-37744. [CrossRef] [PubMed]
100. Gupta, S.K.; Guo, X.; Durkin, S.S.; Fryrear, K.F.; Ward, M.D.; Semmes, O.J. Human T-cell leukemia virus type 1 Tax oncoprotein prevents DNA damage-induced chromatin egress of hyperphosphorylated CHK2. J. Biol. Chem. 2007, 282, 29431-29440. [CrossRef] [PubMed]
101. Durkin, S.S.; Guo, X.; Fryrear, K.A.; Mihaylova, V.T.; Gupta, S.K.; Belgnaoui, S.M.; Haoudi, A.; Kupfer, G.M.; Semmes, O.J. HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase. J. Biol. Chem. 2008, 283, 36311-36320. [CrossRef] [PubMed]
102. Ho, Y.K.; Zhi, H.; Bowlin, T.; Dorjbal, B.; Philip, S.; Zahoor, M.A.; Shih, H.M.; Semmes, O.J.; Schaefer, B.; Glover, J.N. et al. HTLV-1 tax stimulates ubiquitin E3 ligase, ring finger protein 8, to assemble lysine 63-linked polyubiquitin chains for TAK1 and IKK activation. PLoS Pathog. 2015, 11, e1005102. [CrossRef] [PubMed]
103. Deng, L.; Wang, C.; Spencer, E.; Yang, L.; Braun, A.; You, J.; Slaughter, C.; Pickart, C.; Chen, Z.J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103, 351-361. [CrossRef]
104. Ea, C.K.; Deng, L.; Xia, Z.P.; Pineda, G.; Chen, Z.J. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 2006, 22, 245-257. [CrossRef] [PubMed]
105. Liu, S.; Chen, Z.J. Expanding role of ubiquitination in NF-κB signaling. Cell Res. 2011, 21, 6-21. [CrossRef] [PubMed]
106. Adhikari, A.; Xu, M.; Chen, Z.J. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 2007, 26, 3214-3226. [CrossRef] [PubMed]
107. Shembade, N.; Harhaj, N.S.; Yamamoto, M.; Akira, S.; Harhaj, E.W. The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation. J. Virol. 2007, 81, 13735-13742. [CrossRef] [PubMed]
108. Shibata, Y.; Tanaka, Y.; Gohda, J.; Inoue, J. Activation of the ikappab kinase complex by HTLV-1 tax requires cytosolic factors involved in tax-induced polyubiquitination. J. Biochem. 2011, 150, 679-686. [CrossRef] [PubMed]
109. Wang, C.; Long, W.; Peng, C.; Hu, L.; Zhang, Q.; Wu, A.; Zhang, X.; Duan, X.; Wong, C.C.; Tanaka, Y. et al. HTLV-1 tax functions as a ubiquitin E3 ligase for direct IKK activation via synthesis of mixed-linkage polyubiquitin chains. PLoS Pathog. 2016, 12, e1005584. [CrossRef] [PubMed]
110. Wu, X.; Sun, S.C. Retroviral oncoprotein Tax deregulates NF-kappaB by activating Tak1 and mediating the physical association of Tak1-IKK. EMBO Rep. 2007, 8, 510-515. [CrossRef] [PubMed]
111. Ho, Y.K.; Zhi, H.; Debiaso, D.; Philip, S.; Shih, H.M.; Giam, C.Z. HTLV-1 tax-induced rapid senescence is driven by the transcriptional activity of NF-κB and depends on chronically activated IKKα and p65/RelA. J. Virol. 2012, 86, 9474-9483. [CrossRef] [PubMed]
112. Hayakawa, M. Role of K63-linked polyubiquitination in NF-kappaB signalling: Which ligase catalyzes and what molecule is targeted? J. Biochem. 2012, 151, 115-118. [CrossRef] [PubMed]
113. Pinder, J.B.; Attwood, K.M.; Dellaire, G. Reading, writing, and repair: The role of ubiquitin and the ubiquitin-like proteins in DNA damage signaling and repair. Front. Genet. 2013, 4, 45. [CrossRef] [PubMed]
114. Bartocci, C.; Denchi, E.L. Put a ring on it: Regulation and inhibition of RNF8 and RNF168 ring finger E3 ligases at DNA damage sites. Front. Genet. 2013, 4, 128. [CrossRef] [PubMed]
115. Kolas, N.K.; Chapman, J.R.; Nakada, S.; Ylanko, J.; Chahwan, R.; Sweeney, F.D.; Panier, S.; Mendez, M.; Wildenhain, J.; Thomson, T.M. et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 2007, 318, 1637-1640. [CrossRef] [PubMed]
116. Mailand, N.; Bekker-Jensen, S.; Faustrup, H.; Melander, F.; Bartek, J.; Lukas, C.; Lukas, J. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 2007, 131, 887-900. [CrossRef] [PubMed]
117. Lu, C.S.; Truong, L.N.; Aslanian, A.; Shi, L.Z.; Li, Y.; Hwang, P.Y.; Koh, K.H.; Hunter, T.; Yates, J.R., 3rd; Berns, M.W. et al. The RING finger protein RNF8 ubiquitinates Nbs1 to promote DNA double-strand break repair by homologous recombination. J. Biol. Chem. 2012, 287, 43984-43994. [CrossRef] [PubMed]
118. Luo, K.; Zhang, H.; Wang, L.; Yuan, J.; Lou, Z. Sumoylation of MDC1 is important for proper DNA damage response. EMBO J. 2012, 31, 3008-3019. [CrossRef] [PubMed]
119. Siu, Y.T.; Chin, K.T.; Siu, K.L.; Yee Wai, C.E.; Jeang, K.T.; Jin, D.Y. TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats. J. Virol. 2006, 80, 7052-7059. [CrossRef] [PubMed]
120. Nyborg, J.K.; Egan, D.; Sharma, N. The HTLV-1 Tax protein: Revealing mechanisms of transcriptional activation through histone acetylation and nucleosome disassembly. Biochim. Biophys. Acta 2009, 1799, 266-274. [CrossRef] [PubMed]
121. Xu, X.; Heidenreich, O.; Kitajima, I.; McGuire, K.; Li, Q.; Su, B.; Nerenberg, M. Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oncogene 1996, 13, 135-142. [PubMed]
122. Chariot, A. The NF-kappaB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol 2009, 19, 404-413. [CrossRef] [PubMed]
123. Lee, D.F.; Kuo, H.P.; Chen, C.T.; Hsu, J.M.; Chou, C.K.; Wei, Y.; Sun, H.L.; Li, L.Y.; Ping, B.; Huang, W.C. et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 2007, 130, 440-455. [CrossRef] [PubMed]
124. Emmerich, C.H.; Ordureau, A.; Strickson, S.; Arthur, J.S.; Pedrioli, P.G.; Komander, D.; Cohen, P. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc. Natl. Acad. Sci. USA 2013, 110, 15247-15252. [CrossRef] [PubMed]
125. Peloponese, J.M., Jr.; Haller, K.; Miyazato, A.; Jeang, K.T. Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc. Natl. Acad. Sci. USA 2005, 102, 18974-18979. [CrossRef] [PubMed]
126. Ching, Y.P.; Chan, S.F.; Jeang, K.T.; Jin, D.Y. The retroviral oncoprotein tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat. Cell Biol. 2006, 8, 717-724. [CrossRef] [PubMed]
127. Jin, D.Y.; Spencer, F.; Jeang, K.T. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 1998, 93, 81-91. [CrossRef]
128. Liu, B.; Hong, S.; Tang, Z.; Yu, H.; Giam, C.Z. HTLV-I Tax directly binds the Cdc20-associated anaphase-promoting complex and activates it ahead of schedule. Proc. Natl. Acad. Sci. USA 2005, 102, 63-68. [CrossRef] [PubMed]
129. Bellon, M.; Baydoun, H.H.; Yao, Y.; Nicot, C. HTLV-I Tax-dependent and-independent events associated with immortalization of human primary T lymphocytes. Blood 2010, 115, 2441-2448. [CrossRef] [PubMed]
130. Luijsterburg, M.S.; Acs, K.; Ackermann, L.; Wiegant, W.W.; Bekker-Jensen, S.; Larsen, D.H.; Khanna, K.K.; van Attikum, H.; Mailand, N.; Dantuma, N.P. A new non-catalytic role for ubiquitin ligase RNF8 in unfolding higher-order chromatin structure. EMBO J 2012, 31, 2511-2527. [CrossRef] [PubMed]
131. Chahwan, R.; Gravel, S.; Matsusaka, T.; Jackson, S.P. Dma/RNF8 proteins are evolutionarily conserved E3 ubiquitin ligases that target septins. Cell Cycle 2013, 12, 1000-1008. [CrossRef] [PubMed]
132. Plans, V.; Guerra-Rebollo, M.; Thomson, T.M. Regulation of mitotic exit by the RNF8 ubiquitin ligase. Oncogene 2008, 27, 1355-1365. [CrossRef] [PubMed]
133. Ghirlando, R.; Felsenfeld, G. Ctcf: Making the right connections. Genes Dev. 2016, 30, 881-891. [CrossRef] [PubMed]
134. Satou, Y.; Miyazato, P.; Ishihara, K.; Yaguchi, H.; Melamed, A.; Miura, M.; Fukuda, A.; Nosaka, K.; Watanabe, T.; Rowan, A.G. et al. The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome. Proc. Natl. Acad. Sci. USA 2016, 113, 3054-3059. [CrossRef] [PubMed]
135. Landry, S.; Halin, M.; Vargas, A.; Lemasson, I.; Mesnard, J.M.; Barbeau, B. Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein. J. Virol. 2009, 83, 2048-2054. [CrossRef] [PubMed]
136. Barbeau, B.; Peloponese, J.M.; Mesnard, J.M. Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis. Front. Microbiol. 2013, 4, 226. [CrossRef] [PubMed]
137. Mesnard, J.M.; Barbeau, B.; Devaux, C. HBZ, a new important player in the mystery of adult T-cell leukemia. Blood 2006, 108, 3979-3982. [CrossRef] [PubMed]
138. Kawatsuki, A.; Yasunaga, J.I.; Mitobe, Y.; Green, P.L.; Matsuoka, M. HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4 T cells. Oncogene 2016. [CrossRef] [PubMed]
139. Yamamoto-Taguchi, N.; Satou, Y.; Miyazato, P.; Ohshima, K.; Nakagawa, M.; Katagiri, K.; Kinashi, T.; Matsuoka, M. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. PLoS Pathog. 2013, 9, e1003630. [CrossRef] [PubMed]
140. Vernin, C.; Thenoz, M.; Pinatel, C.; Gessain, A.; Gout, O.; Delfau-Larue, M.H.; Nazaret, N.; Legras-Lachuer, C.; Wattel, E.; Mortreux, F. HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating oncomirs. Cancer Res. 2014, 74, 6082-6093. [CrossRef] [PubMed]
141. Kuhlmann, A.S.; Villaudy, J.; Gazzolo, L.; Castellazzi, M.; Mesnard, J.M.; Duc, D.M. HTLV-1 HBZ cooperates with jund to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). Retrovirology 2007, 4, 92. [CrossRef] [PubMed]
142. Yasuma, K.; Yasunaga, J.; Takemoto, K.; Sugata, K.; Mitobe, Y.; Takenouchi, N.; Nakagawa, M.; Suzuki, Y.; Matsuoka, M. HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT). PLoS Pathog. 2016, 12, e1005372. [CrossRef] [PubMed]
143. Charvet, C.; Canonigo, A.J.; Becart, S.; Maurer, U.; Miletic, A.V.; Swat, W.; Deckert, M.; Altman, A. Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression. J. Immunol. 2006, 177, 5024-5031. [CrossRef] [PubMed]